The Landing’s Rule 5 has been appointed to handle a European PR and stakeholder engagement for a new organisation which provides a development pathway in the progression of biomedical innovations based in Amsterdam.
The agency has been taken on to build advocacy and awareness for the European Infrastructure for Translational Medicine (EATRIS) working with more than 70 leading academic institutions across Europe.
EATRIS finance director, Frank de Man said; “We operate in a complex environment and Rule 5 demonstrated that they understand that.
We were impressed with their credentials and are working with them to build sustainable relationships with key journalists and stakeholders.”
Rule 5 managing partner, Rob Brown said the deal marked the agency’s first overseas client for the agency which started in 2013 and opened a London office a year later.
“The team is conducting highly targeted media relations activity and informing the European science and medical communities about the links to world-leading facilities the organisation provides.”
EATRIS’ strategy takes biomedical innovations ‘from bench to bedside’ and provides SMEs and medical companies with a single point of access to the expertise, facilities and clinical patient cohorts, expediting the treatment development process.